Feldman Katz (ravenroof88)
Purpose To evaluate the adding effect of inward decentration of concave spectacle lenses (adding a prismatic effect) on angle control in cases with distance intermittent exotropia (IXT) receiving over-minus therapy.Methods Patients with myopia with IXT angles ≤25 and a Newcastle score (NCS) ≥5 were included. Patients were randomised into two groups. Group 1 received over-minus therapy. Group 2 received over-minus therapy with inward decentration of spectacle glasses to add a base out prism effect equal to one-third of the distance angle of deviation. Success was measured as the percentage of orthotropic cases or those with orthophoria or IXT with improved NCS ≤ 3 and tolerant to treatment. Patients were evaluated 3 months after initial treatment, 3 months after partial weaning and 18 months after complete weaning.Results Sixty-four patients were included, with 32 in each group. The success rates of group 1 were 65.6%, 37.5%, and 31.3%, in group 2, the rates were 75%, 65.6%, and 65.6% for orthotropic cases or those with orthophoria or IXT with improved NCS ≤ 3, respectively. Moreover, NCS significantly improved in group 2 till last visit.Conclusion Adding decentration to over-minus therapy can result in better control of small angle IXT and could be considered as a non-invasive and reversible therapy.Objective This study explored whether the erbium/yttrium/aluminum/garnet (ErYAG) laser irradiated through the photon-induced photoacoustic streaming (PIPS) method would impact on the resin bonding to pulp chamber dentin when used to activate bleaching and/or postbleaching antioxidant treatment. Materials and methods One hundred five dentin samples prepared from freshly extracted human incisors were randomly assigned to seven groups (n = 15) control (no bleaching/antioxidant); CB (conventional bleaching only); MB (modified bleaching only); CB-NI (conventional bleaching+antioxidant with needle irrigation); MB-NI (modified bleaching+antioxidant with needle irrigation); CB-PIPSI (conventional bleaching+antioxidant with PIPS-activated irrigation); and MB-PIPSI (modified bleaching+antioxidant with PIPS-activated irrigation). Bleaching (40% hydrogen peroxide) lasted for 20 min. Modified bleaching groups were irradiated with ErYAG laser using the PIPS tip (2940 nm, 0.90 W, 30 Hz, 30 mJ/pulse, 50-μsec pulse duration) pproach to enable immediate resin restoration of bleached dentin.Alternating Hemiplegia of Childhood (AHC) is a devastating autosomal dominant disorder caused by ATP1A3 mutations, resulting in severe hemiplegia and dystonia spells, ataxia, debilitating disabilities, and premature death. Here, we determine the effects of delivering an extra copy of the normal gene in a mouse model carrying the most common mutation causing AHC in humans, the D801N mutation. We used an adeno-associated virus serotype 9 (AAV9) vector expressing the human ATP1A3 gene under the control of a human Synapsin promoter. We first demonstrated that intracerebroventricular (ICV) injection of this vector in wild-type mice on postnatal day 10 (P10) results in increases in ouabain-sensitive ATPase activity and in expression of reporter genes in targeted brain regions. We then tested this vector in mutant mice. Pargyline supplier Simultaneous intracisterna magna and bilateral ICV injections of this vector at P10 resulted, at P40, in reduction of inducible hemiplegia spells, improvement in balance beam test performance, and prolonged survival of treated mutant mice up to P70. Our study demonstrates, as a proof of concept, that gene therapy can induce favorable effects in a disease caused by a mutation of the gene of a protein that is, at the same time, an ATPase enzyme, a pump, and a signal transduction factor.Background Clinical usefulness of trazodone for delirium in patients receiving palliative care is unclear. Objectives To examine the safety and effectiveness of trazodone for delirium. Design A secondary analysis of a multicenter prospective observation